4
The
Refractive
Ocular
Surface
While
the
newest
diagnostics
and
devices
are
most
common
to
focus
on
for
improved
visual
outcomes,
the
impact
of
a
healthy
ocular
surface
is
often
underestimated.
There
is
a
need
to
focus
on
the
impact
of
the
ocular
surface,
pertaining
to
its
impact
on
cataract
and
refractive
outcomes
and
patient
satisfaction.
ASCRS
members
see
an
average
of
34
patients
per
month
that
are
on
dry
eye
therapies
or
have
punctal
occlusion.
However,
when
asked
about
the
Delphi/DEWS
guidelines
for
treating
aqueous
deficient
dry
eye
and
MGD,
more
than
1/3
of
respondents
were
unaware
of
the
recommended
protocols.
Approximately
1/5
of
all
cataract
and
refractive
patients
present
to
ASCRS
members
with
sufficient
ocular
surface
dysfunction
to
require
advanced
therapies.
Even
with
the
launch
of
advanced
tear
film
diagnostics,
more
than
60%
of
ASCRS
members
still
strongly
agree
or
agree
that
Schirmer's
testing
reliably
increases
diagnostic
accuracy,
while
only
13%
currently
believe
that
advanced
tear
diagnostics
should
be
implemented
at
the
point
of
care.
